Donna Jo McCloskey
Affiliation: National Institutes of Health
- Nurses' perceptions of research utilization in a corporate health care systemDonna Jo McCloskey
National Institutes of Health, National Center for Research Resources, Bethesda, MD, USA
J Nurs Scholarsh 40:39-45. 2008....
- Factor V Leiden as a common genetic risk factor for venous thromboembolismMcDonald K Horne
Department of Laboratory Medicine, National Institute of Nursing Research, National Institutes of Health, Bethesda 20892, USA
J Nurs Scholarsh 38:19-25. 2006..Organizing Framework: An overview of the history, prevalence, and predisposition of the FVL genetic mutation, including who should be tested and how and in what circumstances people with FVL should be treated...
- Selective serotonin reuptake inhibitors: measurement of effect on platelet functionDonna Jo McCloskey
National Institutes of Health, Warren Grant Magnuson Clinical Center, Department of Laboratory Medicine, Bethesda, MD 20892, USA
Transl Res 151:168-72. 2008..Abnormal PFA-100 results suggest additional evaluation for von Willebrand disease, other platelet inhibitory medications, or underlying intrinsic platelet dysfunction...
- Parameters of coagulant and fibrinolytic capacity and activity in postmenopausal women: within-subject variabilityMcDonald K Horne
Department of Laboratory Medicine, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA
Thromb Res 107:229-33. 2002..We observed large differences in within-subject variability among the tests and have demonstrated how such data can be used to estimate the number of times a parameter must be measured to produce a statistically adequate sample...
- Catheter-related thrombosis in pediatricsDonna Jo McCloskey
Department of Laboratory Medicine, Hematology Section, Warren Grant Magnussen Clinical Center, National Institutes of Health, Bethesda, MD, USA
Pediatr Nurs 28:97-102, 105-6. 2002..v.) therapy and blood sampling, but has decreased frequent trips to the clinics or hospitals that are otherwise often required. In recent years family members are using VADs more frequently at home for the delivery of medications...
- Use of heparin versus lepirudin flushes to prevent withdrawal occlusion of central venous access devicesMcDonald K Horne
Department of Laboratory Medicine, W G Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland 20892, USA
Pharmacotherapy 26:1262-7. 2006..To determine whether lepirudin flushes are more effective than heparinized saline in preventing withdrawal occlusion of central venous access devices...